The development and validation of a digital biomarker for remote assessment of Alzheimer's diseases risk
Description
CONCLUSIONS: These results indicate the VSTMBT can provide reliable data when self-administered at-home using an online version of the task and on a personal device. This finding has important implications for remote screening and monitoring
